Issues related to the approval of the R21/Matrix-M malaria vaccine for use in Nigeria and Ghana

被引：2

作者：

Dzi, Kevin T. J. ^{[1
,2
,3
]}

机构：

[1] CHU Vaudois, Inst human med IHM, Dept format & Rech, Lausanne, Switzerland

[2] Univ Lausanne, Lausanne, Switzerland

[3] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland

来源：

FRONTIERS IN PUBLIC HEALTH | 2023年 / 11卷

关键词：

public health; malaria; vaccine efficacy and effectiveness; malaria control and elimination; epidemic;

D O I：

10.3389/fpubh.2023.1237011

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

[No abstract available]

引用

页数：3

共 10 条

[1] Towards malaria control and elimination in Ghana: challenges and decision making tools to guide planning [J].

Awine, Timothy ;

Malm, Keziah ;

Bart-Plange, Constance ;

Silal, Sheetal P. .

GLOBAL HEALTH ACTION, 2017, 10 (01)

[2]

Broadwith P, 2023, Ghana Nigeria Approve Oxford Malaria Vaccine Royal Society of Chemistry

[3]

Chen Cecilia, 2004, Afr Health Sci, V4, P205

[4]

Global Health Division of Parasitic Diseases Malaria, 2018, How Can Malaria Cases and Deaths Be Reduced?

[5]

Maduka Omosivie, 2018, Malariaworld J, V9, P1

[6] Ghana approves Oxford's malaria vaccine for children aged 5 to 36 months [J].

Mahase, Elisabeth .

BMJ-BRITISH MEDICAL JOURNAL, 2023, 381 :p850

[7]

Ouattara A., 2021, Why Have We Waited So Long for a Malaria Vaccine? (commentary)

[8]

Oxford Uo, 2023, R21/Matrix-M Malaria Vaccine Developed by University of Oxford Receives Regulatory Clearance for Use in Ghana

[9] Reasons related to non-vaccination and under-vaccination of children in low and middle income countries: Findings from a systematic review of the published literature, 1999-2009 [J].

Rainey, Jeanette J. ;

Watkins, Margaret ;

Ryman, Tove K. ;

Sandhu, Paramjit ;

Bo, Anne ;

Banerjee, Kaushik .

VACCINE, 2011, 29 (46) :8215-8221

[10]

WHO, 2023, WHO Malaria Fact Sheet

← 1 →